Abnormal expression of epidermal growth factor and its receptor in the forebrain and serum of schizophrenic patients

Molecular Psychiatry

Volumn 7, Issue 7, 2002, Pages 673-682

  Futamura, T ^a   Toyooka, K ^a,b   Iritani, S ^c   Niizato, K ^c   Nakamura, R ^c   Tsuchiya, K ^c   Someya, T ^b   Kakita, A ^a   Takahashi, H ^a   Nawa, H ^a  

^a NIIGATA UNIVERSITY   (Japan)

^b NIIGATA UNIVERSITY   (Japan)

^c TOKYO METROPOLITAN MATSUZAWA HOSPITAL   (Japan)

Author keywords

Dopamine; EGF; ErbB; Haloperidol; Postmortem brain; Striatum

Indexed keywords

EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; HALOPERIDOL; TRANSFORMING GROWTH FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; FEMALE; FOREBRAIN; HUMAN; HUMAN TISSUE; MALE; MONOAMINE METABOLISM; NONHUMAN; PATHOLOGY; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SCHIZOPHRENIA; SERUM; SIGNAL TRANSDUCTION;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; EPIDERMAL GROWTH FACTOR; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSENCEPHALON; RATS; RATS, WISTAR; RECEPTOR, EPIDERMAL GROWTH FACTOR; SCHIZOPHRENIA; TRANSFORMING GROWTH FACTOR ALPHA;

EID: 0036367363     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mp.4001081     Document Type: Article

References (57)

1. Structure-function relationships for the EGF/TGFa family of mitogens
2. Epidermal growth factor (EGF) regulates non-mitogenic functions in differentiated mammalian tissues
3. Roles of transforming growth factor-alpha and related molecules in the nervous system
4. Epidermal growth factor exerts neuronotrophic effects on dopaminergic and GABAergic CNS neurons: Comparison with basic fibroblast growth factor
5. Epidermal growth factor and basic fibroblast growth factor promote the generation of long-term potentiation in the dentate gyrus of anaesthetized rats
6. Trophic stimulation of cultured neurons from neonatal rat brain by epidermal growth factor
7. Neuronal and glial expression of heparin-binding EGF-like growth factor in central nervous system of prenatal and early-postnatal rat
8. Cellular localization of transforming growth factor-alpha mRNA in rat forebrain
9. Epidermal growth factor as a local mediator of the neurotrophic action of vitamin B(12) (cobalamin) in the rat central nervous system
10. The ontogeny of epidermal growth factor receptors during mouse development
11. Epidermal growth factor receptor immunoreactivity in rat brain. Development and cellular localization
12. Localization of immunoreactive epidermal growth factor receptors in human nervous system
13. EGF enhances the survival of dopamine neurons in rat embryonic mesencephalon primary cell culture
14. Epidermal growth factor and basic fibroblast growth factor protect dopaminergic neurons from glutamate toxicity in culture
15. Effect of intracerebroventricular infusion of epidermal growth factor in rats hemitransected in the nigro-striatal pathway
16. Trophic actions of transforming growth factor alpha on mesencephalic dopaminergic neurons developing in culture
17. A strain-independent postnatal neurodegeneration in mice lacking the EGF receptor
18. A null mutation in TGF-alpha leads to a reduction in midbrain dopaminergic neurons in the substantia nigra
19. Effects of tryptophan and serotonin uptake inhibitors on behavior in male transgenic transforming growth factor alpha mice
20. Alterations in brain monoamines and GABAA receptors in transgenic mice overexpressing TGF alpha
21. Effects of repeated administrations of EGF and TGF-alpha on mouse neurobehavioral development
22. Regulation of serotonin transporter gene expression in human glial cells by growth factors
23. Levels of transforming growth factor alpha (TGF-alpha) in human cerebrospinal fluid
24. Interleukin-1 beta, interleukin-6, epidermal growth factor and transforming growth factor-alpha are elevated in the brain from Parkinsonian patients
25. Psychoneuroimmunology and the cytokine action in the CNS: Implications for psychiatric disorders
26. Cytokines in affective disorders and schizophrenia: New clinical and genetic findings
27. The role of inflammatory mediators in the biology of major depression: Central nervous system cytokines modulate the biological substrate of depressive symptoms, regulate stress-responsive systems, and contribute to neurotoxicity and neuroprotection
28. Cytokine and growth factor involvement in long-term potentiation
29. Cytokine and growth factor involvement in schizophrenia - Support for the developmental model
30. Brain-derived neurotrophic factor increases the stimulation-evoked release of glutamate and the levels of exocytosis-associated proteins in cultured cortical neurons from embryonic rats
31. Growth factor-mediated Fyn signaling regulates alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor expression in rodent neocortical neurons
32. The glutamate receptor-mediated regulation of brain-derived neurotrophic factor production by cytokines in central nervous system
33. Neurotrophins and cytokines positively and negatively regulate expression of glutamate receptor on forebrain inhibitory neurons
34. Phenotypic down-regulation of glutamate receptor subunit GluR1 in Alzheimer's disease
35. Abnormal expression of brain-derived neurotrophic factor and its receptor in the corticolimbic system of schizophrenic patients
36. Plasma heparin-binding EGF-like growth factor levels in patients after partial hepatectomy as determined with an enzyme-linked immunosorbent assay
37. Expression of receptors for neuregulins, ErbB2, ErbB3 and ErbB4, in developing mouse cerebellum
38. Structural brain imaging in schizophrenia: A selective review
39. Immunoelectron microscope analysis of epidermal growth factor receptor (EGFR) in isolated Mytilus galloprovincialis (Lam.) digestive gland cells: Evidence for ligand-induced changes in EGFR intracellular distribution
40. The erbB/HER type 1 tyrosine kinase receptor family
41. Signal transduction by receptors with tyrosine kinase activity
42. Heterodimerization and functional interaction between EGF receptor family members: A new signaling paradigm with implications for breast cancer research
43. The neurotrophic action and signalling of epidermal growth factor
44. Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells
45. Glioblastoma-associated circulating monocytes and the release of epidermal growth factor
46. Expression of NMDAR1, GluR1, GluR7, and KA1 glutamate receptor mRNAs is decreased in frontal cortex of 'neuroleptic-free' schizophrenics: Evidence on reversible up-regulation by typical neuroleptics
47. Increases in CSF levels of interleukin-2 in schizophrenia: Effects of recurrence of psychosis and medication status
48. The neuropathology of schizophrenia. A critical review of the data and their interpretation
49. Ectodomain shedding of epidermal growth factor receptor ligands is required for keratinocyte migration in cutaneous wound healing
50. Regulated shedding of syndecan-1 and -4 ectodomains by thrombin and growth factor receptor activation
51. Role of an anti-epidermal growth factor receptor in treating cancer
52. Apoptosis and schizophrenia: Is the tumour suppressor gene, p53, a candidate susceptibility gene?
53. Glutamate receptors, microtubule associated proteins and developmental anomaly in schizophrenia: An hypothesis
54. The biological basis of schizophrenia
55. Schizophrenia as a brain disease. The dopamine receptor story
56. Dopaminergic mechanisms in the pathogenesis of schizophrenia